The neurotransmitter dopamine (DA) is an important molecule bridging the nervous and immune systems. DA through autocrine/paracrine manner modulates the functions of immune effector cells by acting through its receptors present in these cells. DA also has unique and opposite effects on T cell functions. Although DA activates naïve or resting T cells, but it inhibits activated T cells. In addition, changes in the expression of DA receptors and their signaling pathways especially in T cells are associated with altered immune functions in disorders like schizophrenia and Parkinson's disease. These results suggest an immunoregulatory role of DA. Therefore, targeting DA receptors and their signaling pathways in these cells by using DA receptor agonists and antagonists may be useful for the treatment of diseases where DA induced altered immunity play a pathogenic role.
Introduction
Besides conventional roles of neurotransmitters in neural communication, a large amount of evidence indicates that neurotransmitters mediate cross talk between the nervous and immune systems (Eskandari and Sternberg, 2002) . Among these neurotransmitters, the role of DA is particularly interesting because in addition to regulating behavior, movement, endocrine, cardiovascular, renal and gastrointestinal functions (Basu et al., 1995; Chakroborty et al., 2008; Mezey et al., 1999; Missale et al., 1998) , DA can also modulate immune functions (Basu and Dasgupta, 2000) . DA is synthesized by different immune effector cells and its receptors are present in these cells (Basu et al., 1993; Basu and Dasgupta, 2000; Eldrup et al., 1989; Ferrari et al., 2004; Kirillova et al., 2008; Le Fur et al., 1980; McKenna et al., 2002; Nakano et al., 2008 Nakano et al., , 2009 . Furthermore, the sympathetic innervation of lymphoid tissues can also be dopaminergic in nature, particularly during stress (Bencsics et al., 1997; Mignini et al., 2003) . As the majority of recent reports indicate unique interactions between dopamine and T cells, the main focus of this mini-review is on DA mediated regulation of T cell functions.
DA modulates the functions of immune effector cells by acting through its receptors present in these cells
DA is a monoamine catecholamine neurotransmitter, which acts through its D 1 and D 2 classes of receptors present in the target cells (Missale et al., 1998) . The D 1 class includes the D 1 and D 5 subtypes, which on activation increases intracellular cAMP (Missale et al., 1998) . In contrast, the D 2 class of receptors, which includes D 2 , D 3 and D 4 subtypes, inhibits intracellular cAMP on stimulation (Missale et al., 1998) .
Several studies now indicate the presence of DA D 1 , D 2 , D 3 , D 4 and D 5 receptors in normal human leukocytes (Ferrari et al., 2004; Kirillova et al., 2008; McKenna et al., 2002; Nakano et al., 2008 Nakano et al., , 2009 . Among the leukocyte subpopulations, T lymphocytes, monocytes have low, neutrophils, eosinophils have moderate and B, NK cells have high and more consistent expression of DA receptors (McKenna et al., 2002) . In addition, DA D 1 receptors are present in human dendritic cells (Nakano et al., 2008) . Recently, DA uptake system has been identified in the lymphocytes (Amenta et al., 2001; Caronti et al., 2001; Mill et al., 2002) .
Furthermore, dopaminergic innervation of lymphoid tissues through sympathetic nerves has also been described, thereby suggesting direct DA-mediated neural regulation of immune effector 
